论文部分内容阅读
目的:探讨高血压合并冠心病患者接受氨氯地平阿托伐他汀钙片治疗的临床价值。方法:选取怀集县人民医院2015年7月至2016年6月高血压合并冠心病患者90例,根据简单随机化法分为两组,对照组45例接受硝苯地平缓释片治疗,观察组45例则接受氨氯地平阿托伐他汀钙片治疗,对两组高血压合并冠心病患者经相关治疗后的血压、胆固醇等指标。结果:观察组高血压合并冠心病患者治疗后的血脂水平、炎症因子水平以及疗效与对照组患者相比,差异具有统计学意义(P<0.05),两组高血压合并冠心病患者中均未出现病情恶化的情况以及严重不良反应的情况(P>0.05)。结论:氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效显著,可较好改善高血压合并冠心病患者的生活质量。
Objective: To investigate the clinical value of amlodipine atorvastatin calcium tablets in patients with hypertension and coronary heart disease. Methods: Ninety patients with hypertension complicated with coronary heart disease were selected from People’s Hospital of Huaiji County from July 2015 to June 2016. The patients were divided into two groups according to the simple randomization method. In the control group, 45 patients were treated with nifedipine sustained-release tablets. 45 cases received amlodipine atorvastatin calcium treatment, the two groups of patients with hypertension and coronary heart disease after treatment related to blood pressure, cholesterol and other indicators. Results: There were significant differences in the levels of blood lipids, the level of inflammatory cytokines and the therapeutic effect between the observation group and the control group after treatment (P <0.05). There was no significant difference between the two groups in patients with hypertension and coronary heart disease The situation of exacerbation and serious adverse reactions (P> 0.05). Conclusion: Amlodipine atorvastatin calcium treatment of hypertension with coronary heart disease significantly effect, can better improve the quality of life of patients with hypertension and coronary heart disease.